LXRX
Lexicon Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website lexpharma.com
- Employees(FY) 135
- ISIN US5288723027
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: LXRX
Overview:
LXRX is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $778.86 million. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow analysis, and...
Technical Analysis of LXRX 2024-05-31
Overview:
In analyzing the technical indicators for LXRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-07-25 08:00
- 2024-07-24 20:00
- 2024-07-18 09:38
- 2024-07-17 11:15
- 2024-07-16 10:56
- 2024-07-16 08:51
- 2024-07-16 08:00
- 2024-07-15 20:00
- 2024-07-15 08:00
- 2024-07-14 20:00
- 2024-07-11 07:11
- 2024-07-09 06:54
- 2024-07-08 09:45
- 2024-07-08 09:15
- 2024-07-07 21:15
- 2024-06-21 15:53
Sector Update: Health Care Stocks Gain in Late Afternoon(MT Newswires)
- 2024-06-21 08:47
- 2024-06-21 08:00
- 2024-06-20 20:00
- 2024-06-19 08:00
- 2024-06-18 20:00
- 2024-06-18 08:00
- 2024-06-17 20:00
- 2024-06-17 07:04
- 2024-06-14 08:00
- 2024-06-14 05:10
- 2024-06-13 20:00
- 2024-06-11 08:09
- 2024-05-30 04:45
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial(Clinical Trials Arena)
- 2024-05-29 07:30